I beg to move,
That this House has considered the Third Report of the Scottish Affairs Committee, Problem drug use in Scotland follow-up: Glasgow’s Safer Drug Consumption Facility, HC 630, and the Government response, HC 1485.
It is a privilege, as always, to serve under your chairmanship, Mr Vickers. I am very grateful to the Liaison Committee for allocating time for this debate on the Government’s response to the Scottish Affairs Committee’s report on the pilot safer drug consumption facility in Glasgow, known as the Thistle.
The Committee began this inquiry in January 2025, amid ongoing concern that Scotland faces the highest rate of drug-related deaths in Europe. In 2024, 1,017 deaths were recorded, alongside harms including blood-borne viruses and injection wounds. Preliminary figures for 2025 suggest that those numbers are increasing. There is a suspected 8% increase in drug deaths in the first nine months of 2025, compared with the same period in 2024. Those deaths and drug-related harms are very much concentrated in Glasgow, although not exclusively so. To address that, Glasgow City Council Health and Social Care Partnership and other partners launched the Thistle. The Thistle is located on Hunter Street in Glasgow’s east end, and it is the first sanctioned UK safer drug consumption room.
In its first 10 months, the Thistle has had 522 unique visitors and has supervised over 6,000 injecting episodes. During this time there were 78 medical emergencies on site. Now, that might sound like a bad thing, but this means that there have been 78 instances where people have received professional medical intervention, which they might not otherwise have received. This medical intervention treats overdoses and potentially saves lives. There have been no fatalities at the Thistle in the year since it opened.
Our Committee heard that, as a single service, the impact of the Thistle is expected to be highly localised. It is unlikely to shift the dial on national drug death figures, and it is not designed to do so.
The question of cost was an ongoing theme throughout the inquiry. The Thistle is being funded by the Scottish Government, and up to £2.3 million per year has been committed for the duration of the three-year pilot. The Thistle is undoubtedly expensive to run. However, evidence suggests that facilities such as the Thistle can provide value for money by generating savings elsewhere in the health service. Such facilities can reduce costs associated with public injecting, including the costs of hospital admissions, ambulance call-outs and treating blood-borne viruses.
Preventing just six to eight cases of HIV annually could potentially generate savings equivalent to the annual cost of the Thistle. It is right that the Thistle’s costs were properly considered in the Committee’s inquiry because it is a gold-standard model. That means that the value-for-money and harm-reduction capability of a less sophisticated model remains untested. However, with over 1,000 deaths in 2024 alone, the Committee is clear that the scale of Scotland’s emergency necessitates a commensurate response and significant investment.
The report also emphasises how vital a drug checking licence would be in combating drug-related harm. We explained how such a licence would allow support services to better understand drug trends across Glasgow, and to take action in relation to them. That could be key in ensuring that the Thistle achieves maximum effectiveness.
We recommended that the Home Office urgently complete its assessment of Glasgow’s application for a drug checking licence at the Thistle, and I was very pleased to see that the application was approved in October last year. With this licence, Glasgow will become the first city in Scotland where people can legally test drugs for dangerous contaminants. We know that applications for further drug-checking facilities in Aberdeen and Dundee have also been submitted to the Home Office, and we await the outcome of those applications.
I will now make some remarks about the impact of the Thistle on the local community, which has quite rightly been the subject of much media reporting. I highlight how our report emphasises the importance of supporting the community surrounding the Thistle. The concerns of the local community must be taken seriously, which is why our report recommended proactive engagement through the community forum and the development of a responsive communication strategy.
Amid the media commentary, we should also bear in mind that it may take time for the local effects of the Thistle to be fully understood. We are reassured that the ongoing independent evaluation is monitoring the levels of discarded paraphernalia, and the pilot’s wider impact on the community. That is vital, and it will ensure that debate about local impacts is informed by accurate, objective data.
In November last year we published the Government’s response to our report. There is some positive messaging in the response, which we welcome, and the Government have said that they are firmly committed to tackling drug-related harms and to working closely and positively with the Scottish Government. The response also noted
“the importance of evidence-based and high-quality treatment, which engages vulnerable people who use drugs.”
Both those points very much align with the spirit of our report.
When it comes to the Thistle itself, however, I must express some disappointment at the substance of the Government’s response. It states that the Government will “welcome any evidence” emerging from the evaluation of the Thistle. However, it also states that the Government have
“no plans to amend the Misuse of Drugs Act 1971”
to permit the operation of such facilities anywhere in the UK. It is difficult to see how full and proper consideration can be given to the Thistle’s evaluation unless the Government are at least open-minded to considering legal changes. As our report says,
“Any intervention found to be effective at saving lives and reducing harm should not be dismissed.”
Experts and evidence, rather than preconceived ideas, should determine the facility’s future.
I directly asked the Prime Minister about this issue during a public session of the Liaison Committee in December. Given the scale of Scotland’s drug crisis, I asked whether he would reconsider the Government’s opposition to amending the law if the Thistle’s evaluation shows it to be effective. He said that the Government had looked at it but does not intend to do so. He also said that legal decisions pertaining to the Thistle are best taken by those in Scotland, and that this should not lead to a UK-wide changing of drugs law. Unfortunately, that response appears not to recognise that drugs law is reserved. In her response to this debate, I hope the Minister will help us to understand how the Government can welcome evidence while remaining closed as to what that evidence might say.
Since the publication of our report, the issues we raised have only become more prescient. Interest has developed in additional safer drug consumption facilities elsewhere in Scotland. In Edinburgh, a feasibility study for a similar facility was undertaken in late 2024. That work confirmed strong local need for a facility, and identified two potential sites in the city. Then, in September 2025, the Edinburgh integration joint board announced plans to launch a formal public consultation early this year as part of developing a business case for a facility.
The Lord Advocate’s current statement of prosecution policy, however, would not cover any other sites. It is specifically worded in such a way that it covers the Thistle facility and nowhere else. That prosecutorial statement indicates that it is not in the public interest to prosecute people at the Thistle.
Our report concludes that relying on separate prosecution policies for multiple facilities is undesirable. If there are to be other safer drug consumption facilities beyond Glasgow, it is even more important that the UK Government address the issues highlighted in our report by establishing a clear legal basis that applies across Scotland. That would require legislation by the UK Government and Parliament.
The issues covered in our report are more relevant now than ever, because drug consumption trends in Scotland are changing rapidly. Inhalation is becoming much more prevalent. We highlight the expert medical advice from Dr Saket Priyadarshi and others that shows that inhalation is a safer method of consumption than injection. Introducing an inhalation space could expand the reach of the Thistle by attracting those who smoke and inhale drugs rather than inject them. Dr Priyadarshi describes how it would reduce the appalling physical harm caused by injecting at wound sites.
The Thistle does not currently have inhalation facilities. Such facilities would be prohibited under both reserved and devolved legislation, most notably Scotland’s smoking ban. Our report makes it clear that, for the Thistle to be effective, it must be able to meet the needs of the population it is trying to help. An inhalation room could therefore be key to maximising the Thistle’s effectiveness, and a fair evaluation of the facility’s full potential efficacy could be inhibited without one.
Since the publication of our report, the Glasgow City integration joint board has announced plans potentially to provide an inhalation space within the Thistle. The board has approved plans to develop a full business case to explore it, and our report calls for any application to enable an inhalation space to be considered by the UK Government on its merits.
In response to our report, the Government said that it “does not support” enabling inhalation. The Government suggest that it would be for the Lord Advocate, rather than the UK Government, to grant an exemption to reserved legislation. I hope the Minister might reflect on the logic that granting exemptions to reserved legislation is best done by the Lord Advocate through prosecutorial discretion rather than by the UK Government, who retain responsibility for drugs law.
I have one further point. The Thistle is already operating, and it may evolve to provide more services in future. Meanwhile, it is becoming increasingly likely that similar facilities may be established elsewhere in Scotland. All of that is happening whether the UK Government approve or not. To a certain extent, that reflects the proper operation of devolution and Scotland’s separate legal system, which enables Scotland to take a different path from the rest of the UK.
However, as our report sets out, it would be undesirable for the Thistle or any other future facility to operate, potentially indefinitely, under the Lord Advocate’s prosecutorial discretion. The UK Government should recognise these realities, and if the Thistle is deemed a success, they should work with the Scottish Government to ensure that there is a full, sustainable legal framework for such facilities. If they do not do so, the Government would be permitting the current unstable legal position to persist. I look forward to hearing the contributions of other Members and the Minister.